Lee Miyoung, Gudas Lorraine J, Saavedra Harold I
Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Department of Pharmacology, Weill Medical College of Cornell University, New York, NY, USA.
Methods Mol Biol. 2018;1726:143-151. doi: 10.1007/978-1-4939-7565-5_13.
Chromatin immunoprecipitation (ChIP), originally developed by John T. Lis and David Gilmour in 1984, has been useful to detect DNA sequences where protein(s) of interest bind. ChIP is comprised of several steps: (1) cross-linking of proteins to target DNA sequences, (2) breaking genomic DNA into 300-1000 bp pieces by sonication or nuclease digestion, (3) immunoprecipitation of protein bound to target DNA with an antibody, (4) reverse cross-linking between target DNA and the bound protein to liberate the DNA fragments, and (5) amplification of target DNA fragment by PCR. Since then, the technology has evolved significantly to allow not only amplifying target sequences by PCR, but also sequencing all DNA fragment bound to a target protein, using a variant of the approach called the ChIP-seq technique (1). Another variation, the ChIP-on-ChIP, allows the detection of protein complexes bound to specific DNA sequences (2).
染色质免疫沉淀技术(ChIP)最初由约翰·T·利斯和大卫·吉尔摩于1984年开发,已被用于检测感兴趣的蛋白质所结合的DNA序列。ChIP包括几个步骤:(1)将蛋白质与目标DNA序列交联;(2)通过超声处理或核酸酶消化将基因组DNA断裂成300 - 1000碱基对的片段;(3)用抗体免疫沉淀与目标DNA结合的蛋白质;(4)使目标DNA与结合的蛋白质之间进行反向交联以释放DNA片段;(5)通过PCR扩增目标DNA片段。从那时起,该技术有了显著发展,不仅可以通过PCR扩增目标序列,还可以使用一种称为ChIP-seq技术的方法变体对与目标蛋白质结合的所有DNA片段进行测序(1)。另一种变体ChIP-on-ChIP则可以检测与特定DNA序列结合的蛋白质复合物(2)。